Citadel Advisors’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,262
| Closed | -$22.2K | – | 6802 |
|
|
2023
Q2 | $22.2K | Buy |
+12,262
| New | +$22.2K | ﹤0.01% | 5226 |
|
|
2022
Q1 | – | Sell |
-300,000
| Closed | -$4.91M | – | 7431 |
|
|
2021
Q4 | $4.91M | Sell |
300,000
-6,767
| -2% | -$111K | ﹤0.01% | 2114 |
|
|
2021
Q3 | $3.05M | Sell |
306,767
-167,544
| -35% | -$1.67M | ﹤0.01% | 2538 |
|
|
2021
Q2 | $4.74M | Sell |
474,311
-247,455
| -34% | -$2.47M | ﹤0.01% | 2218 |
|
|
2021
Q1 | $7.19M | Buy |
+721,766
| New | +$7.19M | ﹤0.01% | 1712 |
|